TRAX
First Tracks Biotherapeutics, Inc. · Healthcare
Ecor1 Capital, LLC sold $65.0M of First Tracks Biotherapeutics, Inc.
10% owner
Sold$64,999,990
$13.81Price
4,705,575Shares
−60%Stake
What TRAX did after the filing
- The stock from Thu, Apr 23 open, $18.99
- −12.6%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jun 5 close.
Traded Mon, Apr 20. Filed Wed, Apr 22, 5:07 PM ET, after the close. Returns use the Apr 23 open and the Jun 5 close. Not investment advice.